↓ Skip to main content

Incidence and course of acute coronary syndrome cases after the first wave of the COVID-19 pandemic.

Overview of attention for article published in Kardiologia polska, January 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#34 of 1,202)
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter
9 X users

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Incidence and course of acute coronary syndrome cases after the first wave of the COVID-19 pandemic.
Published in
Kardiologia polska, January 2023
DOI 10.33963/kp.a2022.0250
Pubmed ID
Authors

Justyna Jankowska-Sanetra, Krzyszto Sanetra, Marta Konopko, Monika Kutowicz, Magdalena Synak, Paweł Kaźmierczak, Krzysztof Milewski, Łukasz Kołtowski, Piotr Paweł Buszman

Abstract

The collateral damage caused by the COVID-19 pandemic influences cardiovascular disease patients, mainly acute coronary syndrome (ACS) cases. Additionally, lockdown has caused treatment-related concerns and reluctance, factors that can delay treatment. To analyse the incidence and course of ACS patients following the first COVID-19 wave. The report represents a multi-institutional registry of 10 interventional cardiology departments. ACS patient data were gathered from June to October 2020, the period following the first lockdown in Poland (March 30-May 31, 2020), and compared with the corresponding 2019 timeframe. Patients (2801 and 2620) hospitalized for ACS in 2019 and 2020 (June-October), represent 52.8% and 57.9% of coronary artery disease admissions, respectively. In 2020 vs. 2019, more cases of arterial hypertension (80.2% vs. 71.5%; P <0.001), diabetes (32.7% vs. 28.2%; P <0.001), hyperlipidaemia (53.2% vs. 49.8%; P = 0.01) and smoking history (29.5% vs. 25.8%; P = 0.003) were detected. Median troponin and cholesterol values, as well as glycemia were higher in 2020. Patients were more likely to undergo percutaneous treatment (91.2% vs. 87.5%; P <0.001) and less often referred for surgery (3.7% vs. 4.9%; P = 0.03). No differences in deaths, repeat myocardial infarction, stroke, and/or composite endpoint (major adverse cardiac and cerebrovascular events [MACCE]) were noted. However, suffering from ACS in 2020 (June-October) was a risk factor for mortality based on a multivariable analysis. The COVID-19 pandemic affects ACS patient profile, course of treatment, and increases risk for mortality.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 33%
Unspecified 1 11%
Student > Bachelor 1 11%
Student > Master 1 11%
Unknown 3 33%
Readers by discipline Count As %
Medicine and Dentistry 2 22%
Environmental Science 1 11%
Unspecified 1 11%
Social Sciences 1 11%
Decision Sciences 1 11%
Other 0 0%
Unknown 3 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2022.
All research outputs
#4,779,494
of 26,179,695 outputs
Outputs from Kardiologia polska
#34
of 1,202 outputs
Outputs of similar age
#95,861
of 485,023 outputs
Outputs of similar age from Kardiologia polska
#2
of 41 outputs
Altmetric has tracked 26,179,695 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,202 research outputs from this source. They receive a mean Attention Score of 2.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 485,023 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.